Podcast: The amazing possibilities of facial recognition technology.
Dr. Manel Puig Domingo, a leading endocrinologist in Barcelona, is doing important work on facial recognition and biometrics to see if this technology is...
How do muscles change?
Note: Muscle weakness affects the quality of life in people with acromegaly. Doctora Elena Valassi takes a fascinating look at what happens to muscles...
The critical need for adrenal insufficiency awareness
If you'd like to learn more about Addison's disease, here's a perfect opportunity to do so. The Advanced Practice in Endocrinology Nursing is a comprehensive...
Managing stress and emotional well being
The Chilean pituitary patient advocacy group, Corapehi presents information on the use of traditional Chinese medicine techniques to aid in managing stress and improve...
From the European Society of Endocrinology: Cushing’s syndrome clinical management guidance during the...
This is a series of urgent clinical guidance documents on the management of endocrine conditions in the time of COVID-19. This clinical guidance document...
Podcast: Critical COVID-19 information for pituitary patients
We caught up with Dr. Kevin Yuen, medical director of the Barrow Pituitary Center and the Barrow Neuroendocrinology Clinic in Phoenix, Arizona, and Dr. Lewis...
Things to think about: Coming up on Pituitary World News
From J D Faccinetti - co-founder - One of the unforeseen consequences of this crisis is how it has affected our editorial decisions, that...
The World Alliance of Pituitary Organizations – April 2020 Newsletter
WAPO's Global Pituitary Voice - April 2020 edition - is now available to download.
This newsletter is being released in the midst of the COVID-19...
Exciting news for acromegaly and NET’s from Crinetics Pharmaceuticals!
In a press release today, San Diego, California based Crinetics Pharmaceuticals reports positive results from their Phase Two trial of PALTUSOTINE (the former CRN00808)....
News on Signifor, Signifor LAR, and newly approved Cushing’s drug ISTURISA
Recordati Rare Diseases, Inc., based in Lebanon, NJ, has recently acquired the rights to SIGNIFOR® LAR and the FDA approval for ISTURISA®(osilodrostat). Both products...
